(Coordinated research of chemotherapeutic agents and radiopharmaceuticals)

Technical Report · Mon Jan 14 00:00:00 EST 1991

DOI:https://doi.org/10.2172/6141192· OSTI ID:6141192

Srivastava, P C

The traveler received a United Nations Development Program (UNDP) Award for Distinguished Scientists to visit Indian Research Institutions including Central Drug Research Institute (CDRI), Lucknow, the host institution, in cooperation with the Council of Scientific and Industrial Research (CSIR) of India. At CDRI, the traveler had meetings to discuss progress and future directions of on-going collaborative research work on nucleosides and had the opportunity to initiate new projects with the divisions of pharmacology, biopolymers, and membrane biology. As a part of this program, the traveler also visited Sanjay Gandhi Post Graduate Institute (SGPI) of Medical Sciences, Lucknow; Board of Radiation and Isotope Technology (BRIT) and Bhabha Atomic Research Center (BARC), Bombay; Variable Energy Cyclotron Center (VECC) and Indian Institute of Chemical Biology, Calcutta. He also attended the Indo-American Society of Nuclear Medicine Meeting held in Calcutta. The traveler delivered five seminars describing various aspects of radiopharmaceutical development at the Oak Ridge National Laboratory (ORNL) and discussed the opportunities for exchange visits to ORNL by Indian scientists.

• Research Organization: Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
• Sponsoring Organization: DOE/ER
• DOE Contract Number: AC05-84OR21400
• OSTI ID: 6141192
• Report Number(s): ORNL/FTR-3852; ON: DE91006319
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
DRUGS
RESEARCH PROGRAMS
PHARMACOLOGY
RADIOPHARMACEUTICALS
CHEMOTHERAPY
INDIA
NUCLEAR MEDICINE
NUCLEOSIDES
TRAVEL
ASIA
DEVELOPING COUNTRIES
LABELLED COMPOUNDS
MEDICINE
NUCLEOTIDES
ORGANIC COMPOUNDS
RIBOSIDES
THERAPY
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)